BIOCON
Back to Income Statement
|
BIOCON Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹16,927 Cr | ₹15,262 Cr | ₹14,756 Cr | ₹11,174 Cr | ₹8,184 Cr |
What is the latest Revenue of BIOCON ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹16,927 Cr |
| Mar2025 | ₹15,262 Cr |
| Mar2024 | ₹14,756 Cr |
| Mar2023 | ₹11,174 Cr |
| Mar2022 | ₹8,184 Cr |
How is Revenue of BIOCON Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹16,927 Cr | 10.91 | |
| Mar2025 | ₹15,262 Cr | 3.43 | |
| Mar2024 | ₹14,756 Cr | 32.05 | |
| Mar2023 | ₹11,174 Cr | 36.54 | |
| Mar2022 | ₹8,184 Cr | - | |
Compare Revenue of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹67,159.9 Cr | -0.7% | -5.9% | 15% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | -1.2% | -2.2% | 15.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹227,958.0 Cr | 1% | 16.3% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,990.0 Cr | 3.2% | -0.8% | 38.6% | Stock Analytics | |
| CIPLA | ₹116,141.0 Cr | -0.9% | 1.6% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,604.4 Cr | -1.7% | -0.1% | -6.5% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | -0.7% |
-5.9% |
15% |
| SENSEX | -0.7% |
0.1% |
-3.4% |
You may also like the below Video Courses